Evidence map›Paper›PMID 33833094›Full record

ArticleScience (New York, N.Y.)2021

Comment on "Tumor-initiating cells establish an IL-33-TGF-β niche signaling loop to promote cancer progression".

Jasper B J Kamphuis, William P M Worrall, Julien Stackowicz, Aurélie Mougel, Emilie Mauré, Eva Conde, Pierre Bruhns, Laurent Guilleminault, Nicolas Gaudenzio, Jinmiao Chen and 2 more

Open access · greenAbstract readComment
PubMed Publisher
In one paragraph

Article in Science (New York, N.Y.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 3 countries.

Jasper B J Kamphuis *Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), INSERM U1291, University of Toulouse, CNRS U5282, 31024 Toulouse, France.ORCID https://orcid.org/0000-0002-8494-613X
William P M Worrall *Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), INSERM U1291, University of Toulouse, CNRS U5282, 31024 Toulouse, France.ORCID https://orcid.org/0000-0003-2507-8173
Julien StackowiczUnit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR1222 INSERM, 75015 Paris, France.
Aurélie MougelToulouse Institute for Infectious and Inflammatory Diseases (Infinity), INSERM U1291, University of Toulouse, CNRS U5282, 31024 Toulouse, France.ORCID https://orcid.org/0000-0002-8761-080X
Emilie MauréToulouse Institute for Infectious and Inflammatory Diseases (Infinity), INSERM U1291, University of Toulouse, CNRS U5282, 31024 Toulouse, France.ORCID https://orcid.org/0000-0002-2621-0634
Eva CondeUnit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR1222 INSERM, 75015 Paris, France.ORCID https://orcid.org/0000-0002-5545-7054
Pierre BruhnsUnit of Antibodies in Therapy and Pathology, Institut Pasteur, UMR1222 INSERM, 75015 Paris, France.ORCID https://orcid.org/0000-0002-4709-8936
Laurent GuilleminaultToulouse Institute for Infectious and Inflammatory Diseases (Infinity), INSERM U1291, University of Toulouse, CNRS U5282, 31024 Toulouse, France.ORCID https://orcid.org/0000-0002-7344-8290
Nicolas GaudenzioUnité de Différenciation Epithéliale et Autoimmunité Rhumatoïde (UDEAR), UMR 1056, INSERM, Université de Toulouse, 31059 Toulouse, France.ORCID https://orcid.org/0000-0002-5648-509X
Jinmiao ChenSingapore Immunology Network, Agency for Science, Technology and Research, 138648 Singapore.ORCID https://orcid.org/0000-0001-7547-6423
Rebecca GentekCentre for Inflammation Research, University of Edinburgh, EH16 4TJ Edinburgh, UK.ORCID https://orcid.org/0000-0001-6574-7242
Laurent L ReberToulouse Institute for Infectious and Inflammatory Diseases (Infinity), INSERM U1291, University of Toulouse, CNRS U5282, 31024 Toulouse, France. laurent.reber@inserm.fr.ORCID https://orcid.org/0000-0003-3384-6769
Centre National de la Recherche Scientifique · FRInserm · FRCentre for Inflammation Research · GBSingapore Immunology Network · SG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Taniguchi

Indexed as

Interleukin-33NeoplasmsHumansNeoplastic Stem CellsReceptors, IgETransforming Growth Factor betaInterleukin-33Receptors, IgETransforming Growth Factor beta

Identifiers

PMID33833094
OpenAlexW3147769968

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.